{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:15:42Z","timestamp":1794629742637,"version":"4.9.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13000-018-0690-3","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T23:41:44Z","timestamp":1518478904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Robert W.","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Middlebrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle R.","family":"Covington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Oelschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico A.","family":"Monzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"690_CR1","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199\u2013206.","journal-title":"J Clin Oncol"},{"key":"690_CR2","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","volume":"28","author":"CM Balch","year":"2010","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol. 2010;28:2452\u20139.","journal-title":"J Clin Oncol"},{"key":"690_CR3","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1200\/JCO.1998.16.6.2253","volume":"16","author":"JE Gershenwald","year":"1998","unstructured":"Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, Lee JJ, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253\u201360.","journal-title":"J Clin Oncol"},{"key":"690_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599\u2013609.","journal-title":"N Engl J Med"},{"key":"690_CR5","doi-asserted-by":"publisher","first-page":"1471147","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. AJCC Cancer Staging Manual 7th edition-melanoma. Ann Surg Oncol. 2010;17:1471147\u20134.","journal-title":"Ann Surg Oncol"},{"key":"690_CR6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/jid.2014.452","volume":"135","author":"DC Whiteman","year":"2015","unstructured":"Whiteman DC, Baade PD, Olsen CM. More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia. J Invest Dermatol. 2015;135:1190\u20133.","journal-title":"J Invest Dermatol"},{"key":"690_CR7","doi-asserted-by":"publisher","first-page":"djv294","DOI":"10.1093\/jnci\/djv294","volume":"108","author":"WR Shaikh","year":"2016","unstructured":"Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, Geller AC, Halpern AC. Melanoma Thickness and Survival Trends in the United States, 1989 to 2009. J Natl Cancer Inst. 2016;108:djv294.","journal-title":"J Natl Cancer Inst"},{"key":"690_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jaad.2015.01.009","volume":"72","author":"P Gerami","year":"2015","unstructured":"Gerami P, Cook RW, Russell MC, Wilkinson J, Amaria RN, Gonzalez R, et al. Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy. J Am Acad Dermatol. 2015;72:780\u20135. e3","journal-title":"J Am Acad Dermatol"},{"key":"690_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","volume":"21","author":"P Gerami","year":"2015","unstructured":"Gerami P, Cook RW, Wilkinson J, Russell MC, Dhillon N, Amaria RN, et al. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma. Clin Cancer Res. 2015;21:175\u201383.","journal-title":"Clin Cancer Res"},{"key":"690_CR10","unstructured":"Sun F, Bruening W, Uhl S, Ballard R, Tipton K, Schoelles K. Quality, Regulation and Clinical Utility of Laboratory-developed Molecular Tests. Rockville, MD: Agency for Healthcare Research and Quality (US); 2010."},{"issue":"Suppl 6","key":"690_CR11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2011.0138","volume":"9","author":"PF Engstrom","year":"2011","unstructured":"Engstrom PF, Bloom MG, Demetri GD, Febbo PG, Goeckeler W, Ladanyi M, et al. NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement. J Natl Compr Cancer Netw. 2011;9(Suppl 6):S1\u201316.","journal-title":"J Natl Compr Cancer Netw"},{"key":"690_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GIM.0b013e318184137c","volume":"11","author":"SM Teutsch","year":"2009","unstructured":"Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, et al. The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP working group. Genet Med. 2009;11:3\u201314.","journal-title":"Genet Med"},{"key":"690_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-017-0520-1","volume":"10","author":"EC Hsueh","year":"2017","unstructured":"Hsueh EC, DeBloom JR, Lee J, Sussman JJ, Covington KR, Middlebrook B, et al. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test. J Hematol Oncol. 2017;10:152.","journal-title":"J Hematol Oncol"},{"key":"690_CR14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1080\/03007995.2016.1192997","volume":"32","author":"AC Berger","year":"2016","unstructured":"Berger AC, Davidson RS, Poitras JK, Chabra I, Hope R, Brackeen A, et al. Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients. Curr Med Res Opin. 2016;32:1599\u2013604.","journal-title":"Curr Med Res Opin"},{"key":"690_CR15","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1373\/clinchem.2006.076497","volume":"53","author":"M Cronin","year":"2007","unstructured":"Cronin M, Sangli C, Liu ML, Pho M, Dutta D, Nguyen A, et al. Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin Chem. 2007;53:1084\u201391.","journal-title":"Clin Chem"},{"key":"690_CR16","doi-asserted-by":"publisher","first-page":"E2297","DOI":"10.1210\/jc.2012-1923","volume":"97","author":"PS Walsh","year":"2012","unstructured":"Walsh PS, Wilde JI, Tom EY, Reynolds JD, Chen DC, Chudova DI, et al. Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules. J Clin Endocrinol Metab. 2012;97:E2297\u2013306.","journal-title":"J Clin Endocrinol Metab"},{"key":"690_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jmoldx.2012.08.003","volume":"15","author":"J Lade-Keller","year":"2013","unstructured":"Lade-Keller J, R\u00f8mer KM, Guldberg P, Riber-Hansen R, Hansen LL, Steiniche T, et al. Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas. J Mol Diagn. 2013;15:70\u201380.","journal-title":"J Mol Diagn"},{"key":"690_CR18","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443\u201354.","journal-title":"N Engl J Med"},{"key":"690_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/cgt.2015.39","volume":"22","author":"M Dietel","year":"2015","unstructured":"Dietel M, J\u00f6hrens K, Laffert MV, Hummel M, Bl\u00e4ker H, Pfitzner BM, et al. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance. Cancer Gene Ther. 2015;22:417\u201330.","journal-title":"Cancer Gene Ther"},{"key":"690_CR20","first-page":"1","volume":"10","author":"Health Quality Ontario","year":"2010","unstructured":"Health Quality Ontario. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. Ont Health Technol Assess Ser. 2010;10:1\u201357.","journal-title":"Ont Health Technol Assess Ser"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-018-0690-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:53:44Z","timestamp":1550019224000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-018-0690-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1186\/s13000-018-0690-3","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"7 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional review board approval was not required because this analysis is exempt from the regulatory review requirements as set forth in section 46.101 (b) of 45 CFR 46. Patient consent was not required given the retrospective nature of the study and the use of aggregate de-identified data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of Castle Biosciences, Inc. and hold stock in the company.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"13"}}